FIELD: medicine.
SUBSTANCE: method has stages for manufacturing medical device and introducing effective dose of Linezolid.
EFFECT: improved infection prophylaxis in medical purpose devices.
17 dwg, 11 dwg, 6 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PARENTERAL INTRAVENOUS AND PERORAL INTRODUCTION OF OXAZOLIDINONES FOR TREATMENT OF INFECTIOUS FOOT LESIONS IN DIABETES | 2003 |
|
RU2354372C2 |
| IMIDAZO[1,2-A]PYRIDINE COMPOUNDS, SYNTHESIS THEREOF AND METHODS OF USING SAME | 2010 |
|
RU2608611C2 |
| 5,5-HETEROAROMATIC ANTI-INFECTIOUS COMPOUNDS | 2013 |
|
RU2696278C2 |
| OXAZOLIDINONE DERIVATIVES, METHOD FOR PREPARING THEREOF (VERSIONS) AND BASED PHARMACEUTICAL COMPOSITION | 2006 |
|
RU2417223C2 |
| NOVEL ANTIBACTERIAL COMPOUNDS | 2007 |
|
RU2444526C2 |
| METHOD FOR OVERCOMING GENTAMYCIN RESISTANCE IN METHICILLIN-RESISTANT S. AUREUS STRAINS | 2013 |
|
RU2553601C2 |
| NEW ANTIMICROBIAL AGENTS | 2009 |
|
RU2522582C2 |
| MONOMER DERIVATIVES OF GLYCOPEPTIDE ANTIBIOTIC | 2005 |
|
RU2424248C2 |
| COMBINED THERAPEUTIC AGENTS CONTAINING OXAZOLIDINONES-QUINOLONES INTENDED FOR TREATMENT OF BACTERIAL INFECTIONS | 2014 |
|
RU2675847C2 |
| THERAPY WITH ANTIBIOTICS | 2016 |
|
RU2736485C2 |
